Cargando…

Oral anticancer agent medication adherence by outpatients

In the present study, medication adherence and factors affecting adherence were examined in patients taking oral anticancer agents. In June 2013, 172 outpatients who had been prescribed oral anticancer agents by Ogaki Municipal Hospital (Ogaki, Gifu, Japan) completed a questionnaire survey, with ans...

Descripción completa

Detalles Bibliográficos
Autores principales:	KIMURA, MICHIO, USAMI, EISEKI, IWAI, MINA, NAKAO, TOSHIYA, YOSHIMURA, TOMOAKI, MORI, HIROMI, SUGIYAMA, TADASHI, TERAMACHI, HITOMI
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2014
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4186627/ https://www.ncbi.nlm.nih.gov/pubmed/25295117 http://dx.doi.org/10.3892/ol.2014.2480

Ejemplares similares

Evaluation of hypokalemia and potassium supplementation during administration of liposomal-amphotericin B
por: USAMI, EISEKI, et al.
Publicado: (2014)

Pituitary-Related Adverse Events and Onset Patterns Caused by Immune Checkpoint Inhibitors: Analysis Using the Japanese Adverse Drug Event Report Database
por: Asano, Hiroki, et al.
Publicado: (2023)

Side Effects, Self-Management Activities, and Adherence to Oral Anticancer Agents
por: Jiang, Yun, et al.
Publicado: (2019)

Tranilast enhances the effect of anticancer agents in osteosarcoma
por: Nakashima, Takayuki, et al.
Publicado: (2019)

Provider‐ and patient‐level predictors of oral anticancer agent initiation and adherence in patients with metastatic renal cell carcinoma
por: Spees, Lisa P., et al.
Publicado: (2021)

Changes in the quality of medicines during storage under LED lighting and consideration of countermeasures
por: Yamashita, Shuuji, et al.
Publicado: (2018)

Barriers and facilitators associated with implementing interventions to support oral anticancer agent adherence in academic and community cancer center settings
por: Muluneh, Benyam, et al.
Publicado: (2023)

The Impact of Outpatient Chemotherapy-Related Adverse Events on the Quality of Life of Breast Cancer Patients
por: Tachi, Tomoya, et al.
Publicado: (2015)

Preclinical Investigations of PM01183 (Lurbinectedin) as a Single Agent or in Combination with Other Anticancer Agents for Clear Cell Carcinoma of the Ovary
por: Takahashi, Ryoko, et al.
Publicado: (2016)

Supporting adherence to oral anticancer agents: clinical practice and clues to improve care provided by physicians, nurse practitioners, nurses and pharmacists
por: Timmers, Lonneke, et al.
Publicado: (2017)

Adherence to Oral Hypoglycemic Agents in Hawaii
por: Lee, Rachel, et al.
Publicado: (2005)

Evaluation of the Individual Safe Correction of Antipsychotic Agent Polypharmacy in Japanese Patients with Chronic Schizophrenia: Validation of Safe Corrections for Antipsychotic Polypharmacy and the High-Dose Method
por: Yamanouchi, Yoshio, et al.
Publicado: (2015)

Flavonoids as Anticancer Agents
por: Kopustinskiene, Dalia M., et al.
Publicado: (2020)

A mixed method study design to explore the adherence of haematological cancer patients to oral anticancer medication in a multilingual and multicultural outpatient setting: The MADESIO protocol
por: Michiels, Sandra, et al.
Publicado: (2021)

Synthesis of oxamide-hydrazone hybrid derivatives as potential anticancer agents
por: Dehbid, Mina, et al.
Publicado: (2022)

Patient satisfaction with information on oral anticancer agent use
por: Boons, Christel C. L. M., et al.
Publicado: (2017)

Anticancer agents : frontiers in cancer chemotherapy /
Publicado: (2001)

Adherent Monomer-Misfolded SOD1
por: Watanabe, Yasuhiro, et al.
Publicado: (2008)

Subset Analysis for Screening Drug–Drug Interaction Signal Using Pharmacovigilance Database
por: Noguchi, Yoshihiro, et al.
Publicado: (2020)

Review of Statistical Methodologies for Detecting Drug–Drug Interactions Using Spontaneous Reporting Systems
por: Noguchi, Yoshihiro, et al.
Publicado: (2019)

The impact of side effects from outpatient chemotherapy on presenteeism in breast cancer patients: a prospective analysis
por: Tachi, Tomoya, et al.
Publicado: (2016)

Impact of pharmacist counseling on reducing instances of adverse events that can affect the quality of life of chemotherapy outpatients with breast Cancer
por: Tanaka, Kazuhide, et al.
Publicado: (2018)

Evaluation of treatment adherence in outpatients with schizophrenia
por: Chaudhari, Bhushan, et al.
Publicado: (2017)

Cutaneous adverse events and quality of life in outpatients receiving anticancer agents: results from an observational, cross-sectional study
por: Suh Oh, Hae-Jin, et al.
Publicado: (2020)

Radiation Recall with Anticancer Agents
por: Burris, Howard A., et al.
Publicado: (2010)

Bacteriocins as Potential Anticancer Agents
por: Kaur, Sumanpreet, et al.
Publicado: (2015)

Anticancer Agents Targeted to Sirtuins
por: Kozako, Tomohiro, et al.
Publicado: (2014)

Thiadiazole derivatives as anticancer agents
por: Szeliga, Monika
Publicado: (2020)

Benzothiazole derivatives as anticancer agents
por: Irfan, Ali, et al.
Publicado: (2019)

Polyoxometalates Impact as Anticancer Agents
por: Carvalho, Fátima, et al.
Publicado: (2023)

Menthol: An underestimated anticancer agent
por: Zhao, Yijia, et al.
Publicado: (2023)

In Vitro Evaluation of Oxoplatin: An Oral Platinum(IV) Anticancer Agent
por: Olszewski, Ulrike, et al.
Publicado: (2009)

Adherence to Oral Anticancer Medications: Evolving Interprofessional Roles and Pharmacist Workforce Considerations
por: Paolella, Gennaro A., et al.
Publicado: (2018)

A Novel Approach to Better Characterize Medication Adherence in Oral Anticancer Treatments
por: Schneider, Marie Paule, et al.
Publicado: (2019)

Factors Affecting Medication Adherence in Children Receiving Outpatient Pharmacotherapy and Parental Adherence
por: Nagae, Masaharu, et al.
Publicado: (2015)

Effect of Dipeptidyl Peptidase-4 Inhibitors vs. Metformin on Major Cardiovascular Events Using Spontaneous Reporting System and Real-World Database Study
por: Noguchi, Yoshihiro, et al.
Publicado: (2022)

Therapeutic strategies with oral fluoropyrimidine anticancer agent, S-1 against oral cancer()
por: Harada, Koji, et al.
Publicado: (2017)

Pseudohypoglycemia or hyperglycemia caused by interference with self‐monitoring blood glucose measurements in anticancer ascorbic acid therapy
por: Kimura, Takekazu, et al.
Publicado: (2013)

Investigation of Intervention Solutions to Enhance Adherence to Oral Anticancer Medicines in Adults: Overview of Reviews
por: Dang, Thu Ha, et al.
Publicado: (2022)

Predictors of adherence to oral anticancer medications: An analysis of 2010-2018 US nationwide claims
por: Vyas, Ami, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6cbh5lhd2lirhf8bovt0c0fpbt